Pulmonary Drug Delivery Systems Market, By Product Type (Nebulizers, MDIs, DPIs), By Application (Asthma, COPD, Cystic Fibrosis), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportun

Pulmonary Drug Delivery Systems Market, By Product Type (Nebulizers, MDIs, DPIs), By Application (Asthma, COPD, Cystic Fibrosis), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Orally inhaled and nasal drug products (OINDPs) are the products which include metered dose (MDIs), dry powder inhalers (DPIs), nasal sprays and nebulizers. According to FDA, respiratory inhalers are classified under Class II medical devices. All inhaled products have to undergo mandatory test for extractables, leachables and microbial contaminants. Specific tests for OINDPs include aerodynamic particle size distribution (APSD) and delivered dose uniformity (DDU). These tests are regarded as key parameters for assessing performance of the OINDPs. In addition, nasal sprays and MDIs are supplemented by tests to monitor the performance of the actuator and metering valve such as plume geometry and spray pattern.

Restraints of the Global Pulmonary Drug Delivery Systems Market

Major factors hampering the growth of the pulmonary drug delivery systems market during the forecast period constitutes of stringent regulations, and complications in use.

Key features of the study:

This report provides in-depth analysis of the global pulmonary drug delivery systems market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global pulmonary drug delivery systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include 3M Health Care, Allied Healthcare Products, Inc., AstraZeneca plc, Boehringer Ingelheim, CareFusion Corporation, GF Health Products, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Omron Healthcare, Inc., Glenmark Pharmaceuticals, PARI Respiratory Equipment, Inc., and Philips Healthcare.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global pulmonary drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Pulmonary Drug Delivery Systems Market, By Product Type:

Nebulizers

MDIs

DPIs

Global Pulmonary Drug Delivery Systems Market, By Application:

Asthma

COPD

Cystic Fibrosis

Global Pulmonary Drug Delivery Systems Market, By Geography:

North America

By Product Type

Nebulizers

MDIs

DPIs

By Application

Asthma

COPD

Cystic Fibrosis

By Country:

U.S.

Canada

Europe

By Product Type

Nebulizers

MDIs

DPIs

By Application

Asthma

COPD

Cystic Fibrosis

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type

Nebulizers

MDIs

DPIs

By Application

Asthma

COPD

Cystic Fibrosis

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type

Nebulizers

MDIs

DPIs

By Application

Asthma

COPD

Cystic Fibrosis

By Country

Brazil

Argentina

Mexico

Rest of LATAM

Middle East:

By Product Type

Nebulizers

MDIs

DPIs

By Application

Asthma

COPD

Cystic Fibrosis

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type

Nebulizers

MDIs

DPIs

By Application

Asthma

COPD

Cystic Fibrosis

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

3M Health Care*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Allied Healthcare Products, Inc.

AstraZeneca plc

Boehringer Ingelheim

CareFusion Corporation

GF Health Products, Inc.

GlaxoSmithKline plc

Merck & Co., Inc.

Novartis AG

Omron Healthcare, Inc.

Glenmark Pharmaceuticals

PARI Respiratory Equipment, Inc.

Philips Healthcare

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario
4. Global Pulmonary Drug Delivery Systems Market, By Product Type, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Nebulizers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
MDIs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
DPIs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
5. Global Pulmonary Drug Delivery Systems Market, By Application, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
COPD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Cystic Fibrosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
6. Global Pulmonary Drug Delivery Systems Market, By Regions, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
7. Competitive Landscape
Company Profiles
3M Health Care
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Allied Healthcare Products, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Boehringer Ingelheim
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
CareFusion Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GF Health Products, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Omron Healthcare, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Other Major Players
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 25 figures on “Pulmonary Drug Delivery Systems Market – Global forecast to 2027.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook